List of Excipients in API doxazosin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doxazosin
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Aphena Pharma Solutions - Tennessee LLC | DOXAZOSIN | doxazosin | 71610-628 | CELLULOSE, MICROCRYSTALLINE | |
Aphena Pharma Solutions - Tennessee LLC | DOXAZOSIN | doxazosin | 71610-628 | LACTOSE | |
Aphena Pharma Solutions - Tennessee LLC | DOXAZOSIN | doxazosin | 71610-628 | MAGNESIUM STEARATE | |
Aphena Pharma Solutions - Tennessee LLC | DOXAZOSIN | doxazosin | 71610-628 | SODIUM LAURYL SULFATE | |
Aphena Pharma Solutions - Tennessee LLC | DOXAZOSIN | doxazosin | 71610-628 | SODIUM STARCH GLYCOLATE TYPE A POTATO | |
Roerig | CARDURA | doxazosin mesylate | 0049-2710 | CELLULOSE ACETATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing doxazosin
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 | CELLULOSE, MICROCRYSTALLINE |
Major Pharmaceuticals | doxazosin | 0904-5522 | CROSCARMELLOSE SODIUM |
Major Pharmaceuticals | doxazosin | 0904-5522 | LACTOSE MONOHYDRATE |
Major Pharmaceuticals | doxazosin | 0904-5522 | MAGNESIUM STEARATE |
Rising Pharma Holdings Inc | doxazosin | 16571-165 | LACTOSE MONOHYDRATE |
Rising Pharma Holdings Inc | doxazosin | 16571-165 | MAGNESIUM STEARATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for doxazosin
Excipient focus: ALUMINUM OXIDE
doxazosin drug variants containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-739 |
DOH CENTRAL PHARMACY | doxazosin mesylate | 53808-1107 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
doxazosin drug variants containing ANHYDROUS LACTOSE
doxazosin drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
doxazosin drug variants containing CELLULOSE ACETATE
Company | Ingredient | NDC |
---|---|---|
Roerig | doxazosin mesylate | 0049-2710 |
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing CELLULOSE ACETATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
doxazosin drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Method Pharmaceuticals LLC | doxazosin | 58657-822 |
Roerig | doxazosin mesylate | 0049-2710 |
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
doxazosin drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
AvKARE | doxazosin | 42291-258 |
PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
A-S Medication Solutions | doxazosin | 50090-0701 |
A-S Medication Solutions | doxazosin | 50090-0706 |
A-S Medication Solutions | doxazosin | 50090-2434 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 30
doxazosin drug variants containing D&C RED NO. 30
Company | Ingredient | NDC |
---|---|---|
Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 43353-647 |
PD-Rx Pharmaceuticals Inc | doxazosin mesylate | 55289-022 |
Aphena Pharma Solutions - Tennessee LLC | doxazosin mesylate | 67544-273 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing D&C RED NO. 30
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
doxazosin drug variants containing D&C YELLOW NO. 10
doxazosin drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
doxazosin drug variants containing FD&C BLUE NO. 2
doxazosin drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
doxazosin drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
A-S Medication Solutions | doxazosin | 50090-4000 |
Method Pharmaceuticals LLC | doxazosin | 58657-822 |
Aphena Pharma Solutions - Tennessee LLC | doxazosin | 71610-831 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
doxazosin drug variants containing FD&C YELLOW NO. 6
doxazosin drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
doxazosin drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
A-S Medication Solutions | doxazosin | 50090-3927 |
A-S Medication Solutions | doxazosin | 50090-3987 |
NuCare PharmaceuticalsInc | doxazosin | 68071-4892 |
REMEDYREPACK INC | doxazosin | 70518-3965 |
Bryant Ranch Prepack | doxazosin | 71335-2395 |
Roerig | doxazosin mesylate | 0049-2710 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
doxazosin drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
A-S Medication Solutions | doxazosin | 50090-5773 |
Northwind Pharmaceuticals LLC | doxazosin | 51655-109 |
NuCare Pharmaceuticals Inc | doxazosin | 66267-377 |
NuCare PharmaceuticalsInc | doxazosin | 68071-4273 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
doxazosin drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Roerig | doxazosin mesylate | 0049-2710 |
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
doxazosin drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Roerig | doxazosin mesylate | 0049-2710 |
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
doxazosin drug variants containing LACTOSE
doxazosin drug variants not containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
doxazosin drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
doxazosin drug variants containing MAGNESIUM STEARATE
doxazosin drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
A-S Medication Solutions | doxazosin | 50090-2153 |
A-S Medication Solutions | doxazosin | 50090-5540 |
A-S Medication Solutions | doxazosin | 50090-5773 |
Northwind Pharmaceuticals LLC | doxazosin | 51655-109 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
doxazosin drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Method Pharmaceuticals LLC | doxazosin | 58657-822 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
doxazosin drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Roerig | doxazosin mesylate | 0049-2710 |
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
doxazosin drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
doxazosin drug variants containing SILICON DIOXIDE
doxazosin drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
doxazosin drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Roerig | doxazosin mesylate | 0049-2710 |
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
doxazosin drug variants containing SODIUM LAURYL SULFATE
doxazosin drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
AvKARE | doxazosin | 42291-258 |
PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
A-S Medication Solutions | doxazosin | 50090-0701 |
A-S Medication Solutions | doxazosin | 50090-0706 |
A-S Medication Solutions | doxazosin | 50090-2434 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
doxazosin drug variants containing SODIUM STARCH GLYCOLATE TYPE A
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Aurobindo Pharma Limited | doxazosin mesylate | 59651-892 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
doxazosin drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
doxazosin drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
AvKARE | doxazosin | 42291-258 |
PD-Rx Pharmaceuticals Inc | doxazosin | 43063-739 |
A-S Medication Solutions | doxazosin | 50090-0701 |
A-S Medication Solutions | doxazosin | 50090-0706 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
doxazosin drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
doxazosin drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
doxazosin drug variants containing STARCH, CORN
doxazosin drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
doxazosin drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Roerig | doxazosin mesylate | 0049-2710 |
Viatris Specialty LLC | doxazosin mesylate | 58151-078 |
>Company | >Ingredient | >NDC |
doxazosin drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | doxazosin | 0904-5522 |
Rising Pharma Holdings Inc | doxazosin | 16571-165 |
Accord Healthcare Inc | doxazosin | 16729-212 |
Accord Healthcare Inc | doxazosin | 16729-414 |
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxazosin | 23155-092 |
AvKARE | doxazosin | 42291-258 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.